GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Price-to-Funds-From-Operations

Advagene Biopharma Co (ROCO:6709) Price-to-Funds-From-Operations : (As of Jun. 17, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Advagene Biopharma Co (ROCO:6709) Business Description

Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114
Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.